Expanded Potential Stem Cell lines of pig and human cells established
A new approach has enabled researchers to create Expanded Potential Stem Cells (EPSCs) of both pig and human cells. These stem cells have the features of the very first cells in the developing embryo, and can develop into any type of cell. The research from LKS Faculty of Medicine of The University of Hong Kong (HKUMed), the Wellcome Sanger Institute, and the Friedrich-Loeffler-Institut in Germany offers incredible potential for studying human development and regenerative medicine.
The study published in Nature Cell Biology today (3rd June) is the first time scientists have been able to derive stem cells from early pig embryos. Domestic pigs have great potential for biomedical research because of their genetic and anatomical similarities to humans, including comparable organ sizes. Being able to genetically-modify pig stem cells will also be beneficial for animal health and food production.
Stem cells have the ability to develop into other cell types, and existing stem cell lines are already extremely useful for research into development, disease and treatments. However, currently available types of stem cell lines have limitations, and until now it has also not been possible to create embryonic stem cells from pigs and many other farm animals.
“Scientists have been attempting to derive porcine embryonic stem cells for decades without much success. With our Expanded Potential Stem Cell technology, we have now successfully derived and characterised stem cells from porcine preimplantation embryos. We have also established similar human stem cells. Our study represents a significant advance in stem cell research.”
Professor Pentao Liu, the leader of the study from the School of Biomedical Sciences and Stem Cell and Regenerative Medicine Consortium, HKUMed, and previously of the Wellcome Sanger Institute
Since human EPSCs can produce large numbers of placenta cells – called trophoblasts – they offer new opportunities to investigate pregnancy complications such as pre-eclampsia and miscarriages.
EPSCs come from culturing cells from the earliest stage of development, when the fertilised egg has only divided into 4 or 8 cells and the cells retain some totipotency – the ability to produce all cell types.
“These EPSC stem cells possess developmental potency that is not generally seen in conventional embryonic or induced pluripotent stem cells. They have the potential to produce all embryonic and extra-embryonic cell lines – including those in the placenta and yolk sac, turning back the development clock to the very earliest cell type. These cells will enable researchers to study early embryonic development, miscarriage and developmental disorders.”
Dr Xuefui Gao, a first author on the paper from HKUMed, and previously from the Wellcome Sanger Institute
The first EPSCs were created in 2017, when the group targeted key molecular pathways during very early development in mice. At these very earliest embryonic developmental stages, mammalian species are very similar and the cells are like a blank sheet of paper. This study has shown that it is possible to use the same approach to create human EPSCs and also to establish EPSCs from pigs – mammals that had previously been elusive to stem cell researchers.
“Our porcine EPSCs isolated from pig embryos are the first well-characterized pig cell lines worldwide. EPSC’s great potential to develop into any type of cell provides important implications for developmental biology, regenerative medicine, organ transplantation, disease modelling, and screening for drugs.”
Dr Monika Nowak-Imialek, an author on the paper from the Friedrich-Loeffler-Institut (FLI) in Germany
The Latest on: Stem cells
via Google News
The Latest on: Stem cells
- Mt. Juliet woman with ALS fighting for her stem cellson June 24, 2019 at 8:13 pm
A Mt. Juliet woman stricken by a degenerative disease is fighting for bits of her own body tissue. Ashley Vickers is very busy, juggling four kids and a deadly disease. Her symptoms first started ... […]
- Oscar Saxelby-Lee: Stem cell match boy 'doing well'on June 24, 2019 at 6:27 pm
The mother of a boy with leukaemia says he is feeling "well" three weeks after a stem cell transplant. A stem cell match was found for five-year-old Oscar Saxelby-Lee after about 5,000 people joined a ... […]
- Health Care Digest: How California's stem cell institute may help find glaucoma cure; a stealthy biotech with $100M; and moreon June 24, 2019 at 4:59 am
In the 17 years of the Glaucoma Research Foundation's "Catalyst for a Cure" campaign, only one of the researchers selected for the San Francisco-based foundation's three-stage attack on the blinding ... […]
- Switch that decides fate of cells from neural stem cells discoveredon June 24, 2019 at 12:36 am
Neurons and astrocytes are prominent cell types in the cerebral cortex. Neurons are the primary information processing cells in the brain, whereas astrocytes support and modulate their functions. For ... […]
- New study could change our understanding of how stem cells differentiateon June 23, 2019 at 11:32 pm
A pioneering new study led by Florida State University biologists could fundamentally change our understanding of how embryonic stem cells differentiate into specific cell types. The research, ... […]
- Stem cell clinics: Buyers bewareon June 21, 2019 at 1:22 pm
In the last few years, more than 900 private stem cell clinics have opened in the U.S. They claim stem cells will cure everything from arthritis to macular degeneration, autism to erectile dysfunction ... […]
- Development of glial restricted human neural stem cells for oligodendrocyte differentiation in vitro and in vivoon June 21, 2019 at 2:19 am
Adult neural stem cells (NSCs) are operationally defined as multipotent, self-renewing cells in the CNS that are characterized by their ability to differentiate into neurons, astrocytes, and ... […]
- Employers are steering workers toward a controversial stem cell therapyon June 20, 2019 at 6:21 am
A Midwestern grocery chain, Hy-Vee, is taking an unusual — and highly controversial — approach to reducing health care costs. Regenexx has persuaded over 100 employers to include its services in their ... […]
- Stem Cell Company Persuades Employers To Steer Workers Toward Controversial Therapyon June 20, 2019 at 2:00 am
Amanda Lynch, a 42-year-old Australian trapeze artist who lives in Montreal, said she spent $7,700 last year to treat an injured ligament at a Regenexx clinic in Colorado. But she said the ... […]
- First events in stem cells becoming specialized cells needed for organ developmenton June 19, 2019 at 11:41 pm
New research by cell biologists at the University of Toronto provides significant new insight into the very first step stem cells go through to turn into the specialized cells that make up organs. ... […]
via Bing News